Amphastar Pharmaceuticals (AMPH) Net Cash Flow (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Net Cash Flow of $900000.0 for Q1 2026, down 97.1% year-over-year from $31.1 million in Q1 2025, and up 101.95% quarter-over-quarter from -$46.1 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Net Cash Flow (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Net Cash Flow history runs 14 years deep, the most recent figure standing at $900000.0 for Q1 2026.
- In Q1 2026, Net Cash Flow fell 97.1% year-over-year to $900000.0; the TTM figure through Mar 2026 stood at -$11.8 million (up 35.85% YoY), while the FY2025 annual figure was $18.4 million, up 144.68% from the prior year.
- Net Cash Flow for Q1 2026 stood at $900000.0, up from -$46.1 million in the prior quarter.
- The five-year high for Net Cash Flow was $119.8 million in Q3 2023, with the low at -$126.3 million in Q4 2023.
- The 5-year median for Net Cash Flow is $900000.0 (2026), against an average of $2.7 million.
- Peak annual rise in Net Cash Flow reached 1459.14% in 2023, while the deepest fall reached 10738.45% in 2023.
- Amphastar Pharmaceuticals' Net Cash Flow stood at -$1.2 million in 2022, then sank by 10738.45% to -$126.3 million in 2023, then soared by 67.93% to -$40.5 million in 2024, then dropped by 13.79% to -$46.1 million in 2025, then soared by 101.95% to $900000.0 in 2026.
- Business Quant data shows AMPH's Net Cash Flow at $900000.0 in Q1 2026, -$46.1 million in Q4 2025, and $28.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 937.87 Mn | 647.74 Mn | 93.47 Mn | 52.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 52.66 Mn |
| Jun 30, 2026 | 52.66 Mn |
| Mar 31, 2026 | 900,000.00 |
| Mar 31, 2026 | 900,000.00 |
| Dec 31, 2025 | -46.08 Mn |
| Dec 31, 2025 | -46.08 Mn |
| Sep 30, 2025 | 28.62 Mn |
| Sep 30, 2025 | 28.62 Mn |
| Jun 30, 2025 | 4.77 Mn |
| Jun 30, 2025 | 4.77 Mn |
| Mar 31, 2025 | 31.06 Mn |
| Mar 31, 2025 | 31.06 Mn |
| Dec 31, 2024 | -40.50 Mn |
| Dec 31, 2024 | -40.50 Mn |
| Sep 30, 2024 | 2.56 Mn |
| Sep 30, 2024 | 2.56 Mn |
| Jun 30, 2024 | -11.51 Mn |
| Jun 30, 2024 | -11.51 Mn |
| Mar 31, 2024 | 56.95 Mn |
| Mar 31, 2024 | 56.95 Mn |